QA: Inmed Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728328_2026_Inmed_Pharmaceuticals_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728328, Inmed Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 12,867,279
1 IntangibleAssetsNetIncludingGoodwill 1,620,562
2 PropertyPlantAndEquipmentNet 992,199
3 remainder_Assets 100,000
4 LiabilitiesCurrent 1,839,790
5 LiabilitiesNoncurrent 305,755
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 3,009,540
8 SellingGeneralAndAdministrativeExpense 6,805,630
9 ResearchAndDevelopmentExpense 2,906,495
10 remainder_Expenses 501,181
11 remainder_Revenues 5,227,664
12 remainder_NetIncome 203,123
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,580,040
1 Liabilities 2,145,545
2 Expenses 13,222,846
3 Revenues 5,227,664
4 StockholdersEquity 13,434,495
5 NetIncome -7,792,059
6 ComprehensiveNetIncome -7,792,059
7 BaseVar 18,189,609
8 EconomicCapitalRatiobeforeLimitedLiability 2.43
9 EconomicCapitalRatio 3.31

Edgar->Model Mapping

Feature Distribution

Change over Time